Brian Verrier, CEO
OSSIO is a commercial stage medical device company developing and marketing a portfolio of bio-integrative orthopedic fixation implants using a proprietary polymer.
“Questa's investment strengthens our position as the most innovative implant technology in the $16 billion orthopedic fixation market.”
Brian Verrier
CEO
Their story
Orthopedic surgery relies heavily on implants for bone fixation, but traditional metal and bio-resorbable implants come with significant trade-offs. Metal implants often require removal, while bio-resorbable materials can lack the strength needed for secure fixation, leading to complications.
OSSIO was founded in 2014 to address this challenge. Drawing on years of bio-mechanical research, the company developed OSSIOfiber®, an advanced bio-integrative material designed to provide the strength of metal with the benefits of natural bone healing. Unlike traditional implants, OSSIOfiber® allows the body to gradually replace the implant with bone, reducing complications and improving long-term patient outcomes.
By eliminating the need for implant removal and supporting natural healing, OSSIO aims to set a new standard in orthopedic fixation.
.avif)
Our partnership
Our partnership with OSSIO began through our long-standing relationship with CEO Brian Verrier, who we had previously served on the board of Intrinsic Therapeutics. We tracked the company from its inception years before investing. We were impressed with their technology and progress around its groundbreaking OSSIOfiber® technology.
Over time, we became increasingly impressed by the expansion of OSSIO's product suite and the strong feedback from surgeons using its implants. Our investment marks the next step in our partnership, supporting OSSIO’s continued growth and its mission to advance bio-integrative orthopedic solutions.
The team involved
“OSSIO fits squarely into our investment strategy. The company is growing rapidly and has established OSSIOfiber implants as a differentiated and disruptive medical technology with clear patient benefits and passionate surgeon users.”
Ryan Drant, Founder & Managing Partner
Questa Capital
.avif)